|
All Business Categories
|
Millennium Pharmaceuticals , Inc.
Massachusetts, USA Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, co- promotes INTEGRILIN(R) (eptifibatide) ... Cyclacel Limited New Jersey, USA Cyclacel is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and o... Isis Pharmaceuticals , Inc. California, USA Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. Isis has successfully commercialized the world's first an... Accentia Biopharmaceuticals , Inc. Florida, USA Accentia Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of late-stage clinical products in the therapeutic areas of respir... Biomira Inc. Alberta, Canada Biomira is a biotechnology company specializing in developing innovative therapeutic approaches to cancer management. This commitment to the treatment of cancer is currently focuse... California, USA Sunesis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule therapeutics for oncology and other seriou... Affymax , Inc. California, USA Affymax is a biopharmaceutical company that is developing a pipeline of synthetic peptide-based drug candidates against clinically validated targets for the treatment of kidney dis... ACADIA Pharmaceuticals Inc. California, USA ACADIA Pharmaceuticals (Nasdaq: ACAD) is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central... SuperGen , Inc. California, USA SuperGen is developing its anticancer portfolio of six generic products and five enhanced or supergeneric products. The company currently anticipates marketing clearance of its fir... Demegen , Inc. Pennsylvania, USA Demegen develops natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's lead products address import...
First
Prev
[3]
[5]
[7]
[9]
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
19
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[746]
[1465]
[2183]
Next
Last
|
